Next-Generation Sequencing (NGS) Market to Grow at 19.2% CAGR and Projected to Reach US$ 16.35 Billion by 2024- ReportsnReports

Monday, August 27, 2018 Research News
Email Print This Page Comment bookmark
Font : A-A+

PUNE, India, August 27, 2018 /PRNewswire/ --

The key players in the next-generation sequencing market are Illumina,

Inc. (US), Thermo Fisher Scientific, Inc. (US), Pacific Biosciences of California, Inc. (US), BGI (China), PerkinElmer (US), Agilent Technologies (US), QIAGEN N. V. (Germany),
Macrogen Inc. (South Korea), Oxford Nanopore Technologies, Ltd. (UK), and Eurofins Scientific (Luxembourg).

Browse 106 Market Data Tables and 44 Figures spread through 228 Pages and In-depth TOC on "Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024" at .

The global next-generation sequencing market is projected to reach USD 16.35 billion by 2024from USD 5.70 billion in 2018, at a CAGR of 19.2%. The next-generation sequencing market, by technology, is segmented into sequencing by synthesis, ion semiconductor sequencing, single-molecule real-time sequencing, nanopore sequencing, and other sequencing technologies.

Next-Generation Sequencing Market, By Application 

1 Introduction

2 Diagnostics

3 Cancer Diagnostics

4 Infectious Disease Diagnostics

5 Reproductive Health Diagnostics

6 Diagnostic Applications

7 Drug Discovery

8 Agricultural & Animal Research

Next-Generation Sequencing Market, By End User 

1 Introduction

2 Academic Institutes & Research Centers

3 Hospitals & Clinics

4 Pharmaceutical & Biotechnology Companies

Factors such as advancements in NGS platforms, declining NGS capital cost coupled with decreasing cost of sequencing, improving regulatory & reimbursement scenario for NGS-based diagnostic tests, initiatives from government & private bodies for large-scale sequencing projects, and increasing application of NGS in precision medicine & molecular diagnostics are expected to propel growth of this market.

Order the "Next-Generation Sequencing (NGS) Market by Product (NovaSeq, NextSeq, Sequel, Nanopore), Consumables, Bioinformatics, Services (Exome, RNA, DeNovo), Technology (Ion, SMRT), Application (Diagnostics, Cancer), End User (Academia) - Global Forecasts to 2024" Report Now at .

The next-generation sequencing market is segmented into pre-sequencing products & services (DNA fragmentation, end repair, A-tailing, and size selection; library preparation & target enrichment; and quality control), NGS platforms, consumables, services for platforms, sequencing services, and bioinformatics (NGS data analysis, storage, and management).

Target Audience for this Report: 

  • Manufacturers and suppliers of vaccines
  • Research and development companies
  • Medical research laboratories
  • Academic medical centers and universities
  • Research and consulting firms
  • Venture capital firms

The next-generation sequencing market is segmented into academic institutes & research centers, hospitals & clinics, pharmaceutical & biotechnology companies, and other end users. Among these, the academic institutes & research centers segment is expected to account for the largest share of the next-generation sequencing market in 2018.

Download the Sample Brochure of Global Next-Generation Sequencing (NGS) Market Research Now at .

Report covers the next-generation sequencing market in North America (US and Canada), Europe (Germany, France, the UK, Spain, Italy, the Netherlands, and Rest of Europe), Asia Pacific (China, Japan, India, and Rest of Asia Pacific), and the Rest of the World (RoW). North America is expected to account for the largest share of the global next-generation sequencing market in 2018, followed by Europe.

Breakdown of supply-side primary interviews: by company type, designation, and region: 

  • By Company Type: Tier 1 - 40%, Tier 2 - 25%, and Tier 3 - 36%
  • By Designation: C-level - 43%, Director-level - 22%, and Others - 35%
  • By Region: North America - 37%, Europe - 12%, APAC - 41%, and RoW -10%

Another research titled report studies global molecular diagnostics market is expected to reach USD 11.54 billion by 2023 from USD 7.71 billion in 2018, at a CAGR of 8.4%. Growth in this market can primarily be attributed to the high prevalence of infectious diseases and various types of cancers, increasing awareness and acceptance of personalized medicine and companion diagnostics. The key players operating in the global molecular diagnostics market are Roche (Switzerland), Hologic (US), QIAGEN (Netherlands), Abbott (US), and Danaher (US). is available with discount now at .

Explore More Reports on Medical Devices at .

About Us: is an online market research reports library of 500,000+ in-depth studies of over 5000 micro markets. Not limited to any one industry, offers research studies on agriculture, energy and power, chemicals, environment, medical devices, healthcare, food and beverages, water, advanced materials and much more.

Contact: Hrishikesh Patwardhan Tower B5, office 101, Magarpatta SEZ, Hadapsar, Pune-411013, India +1-888-391-5441

Connect with Us:  


RSS/Feeds:  http: //

SOURCE ReportsnReports

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
I agree to the terms and conditions

News A - Z


News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Find a Doctor

Press Release Category

Press Release Archive

Stay Connected

  • Available on the Android Market
  • Available on the App Store